What is WRBY's health score?

Warby Parker Inc. (WRBY) has a TradeApes health score of 57 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is WRBY's estimated fair value?

Based on our 5-year discounted cash flow model, Warby Parker Inc.'s estimated fair value is $15.42 per share, representing a -36.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is WRBY undervalued or overvalued?

Our model currently rates WRBY as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for WRBY... Refresh in a moment for the full analysis.

Warby Parker Inc. (WRBY)

Healthcare Overvalued low mixed

$24.12

Updated: 2026-06-05

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

56 Mixed

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk

70 Healthy

Est. Fair Value $15.42

DCF Upside -36.1%

Sector Rank #1607 of 6826

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.